{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:36:14Z","timestamp":1792643774593,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1435-5","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T07:03:51Z","timestamp":1550473431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hb Knossos (HBB: c.82G\u2009&gt;\u2009T), \u03b2-globin CD 5 (\u2212CT) (HBB: c.17_18delCT) and \u03b4-globin CD 59 (\u2212a) (HBD: c.179delA) mutations in a Syrian patient with \u03b2-thalassemia intermedia"],"prefix":"10.1186","volume":"19","author":[{"given":"Faten","family":"Moassas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Sayah","family":"Nweder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"1435_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nm0896-847","volume":"2","author":"DJ Weatherall","year":"1996","unstructured":"Weatherall DJ, Clegg JB. Thalassemia--a global public health problem. Nat Med. 1996;2:847\u20139.","journal-title":"Nat Med"},{"key":"1435_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-5-11","volume":"5","author":"R Galanello","year":"2010","unstructured":"Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:1\u201315.","journal-title":"Orphanet J Rare Dis"},{"key":"1435_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/hum.2017.228","volume":"29","author":"J Zhang","year":"2018","unstructured":"Zhang J, Yan J, Zeng F. Recent Progress on genetic diagnosis and therapy for \u03b2-thalassemia in China and around the world. Hum Gene Ther. 2018;29:197\u2013203.","journal-title":"Hum Gene Ther"},{"key":"1435_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12185-018-2411-9","volume":"108","author":"C Asadov","year":"2018","unstructured":"Asadov C, Alimirzoeva Z, Mammadova T, Aliyeva G, Gafarova S, Mammadov J. \u03b2-Thalassemia intermedia: a comprehensive overview and novel approaches. Int J Hematol. 2018;108:5\u201321.","journal-title":"Int J Hematol"},{"key":"1435_CR5","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1111\/ijlh.12777","volume":"40","author":"M Vinciguerra","year":"2018","unstructured":"Vinciguerra M, Passarello C, Cassara F, Leto F, Cannata M, Calvaruso G, Renda D, Maggio A, Giambona A. Coheredity of a new silent mutation: c.-29G>T, with a severe beta-thal mutation in a patient with beta-thalassemia intermediate. Int J Lab Hematol. 2018;40:e17\u201320.","journal-title":"Int J Lab Hematol"},{"key":"1435_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03630269.2018.1470534","volume":"12","author":"G Aliyeva","year":"2018","unstructured":"Aliyeva G, Abdulalimov E, Asadov C, Mammadova T, Gafarova S, Guliyeva Y. First report of beta-thalassemia intermedia in a patient compound heterozygous for \u221292 (C>T) and codons 36\/37 (\u2212T) mutations. Hemoglobin. 2018;12:1\u20132.","journal-title":"Hemoglobin"},{"issue":"4","key":"1435_CR7","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.4081\/hr.2017.7447","volume":"9","author":"A Agapidou","year":"2018","unstructured":"Agapidou A, King P, Ng C, Tsitsikas DA. Double heterozygocity for hemoglobin C and beta thalassemia dominant: a rare case of thalassemia intermedia. Hematol Rep. 2018;9(4):7447.","journal-title":"Hematol Rep"},{"key":"1435_CR8","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/ccr3.990","volume":"5","author":"AJ Kelkar","year":"2017","unstructured":"Kelkar AJ, Moses A. Thalassemia intermedia phenotype resulting from rare combination of c.46delT [Codon15 (\u2212T)] mutation of beta globin gene and HPFH3. Clin Case Rep. 2017;5:1107\u201310.","journal-title":"Clin Case Rep"},{"key":"1435_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/03630260600868006","volume":"30","author":"E Pavlou","year":"2006","unstructured":"Pavlou E, Phylactides M, Kyrri A, Kalogerou E, Makariou C, Georgiou I, Delta-thalassemia in Cyprus KM. Hemoglobin. 2006;30:455\u201362.","journal-title":"Hemoglobin"},{"key":"1435_CR10","doi-asserted-by":"publisher","first-page":"12.11","DOI":"10.1146\/annurev-genom-091416-035451","volume":"19","author":"HW Goonasekera","year":"2018","unstructured":"Goonasekera HW, Paththinige CS, Dissanayake VHW. Population screening for Hemoglobinopathies. Annu Rev Genomics Hum Genet. 2018;19:12.11\u201326.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"1435_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5045\/br.2016.51.3.213","volume":"51","author":"H Mansoori","year":"2016","unstructured":"Mansoori H, Asad S, Rashid A, Karim F. Delta beta thalassemia: a rare hemoglobin variant. Blood Res. 2016;51:213\u20134.","journal-title":"Blood Res"},{"key":"1435_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a015032","volume":"2","author":"G Lettre","year":"2012","unstructured":"Lettre G. The search for genetic modifiers of disease severity in the beta-hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2:1\u201312.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1435_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.hemonc.2016.02.003","volume":"9","author":"L Rujito","year":"2016","unstructured":"Rujito L, Basalamah M, Siswandari W, Setyono J, Wulandari G, Mulatsih S, Sofro AS, Sadewa AH, Sutaryo S. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: a study on beta-thalassemia and hemoglobin E\/beta-thalassemia patients in Indonesia. Hematol Oncol Stem Cell Ther. 2016;9:55\u201363.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"1435_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3109\/03630269.2014.978455","volume":"38","author":"H Murad","year":"2014","unstructured":"Murad H, Moassas F, Jarjour R, Mukhalalaty Y, Al-Achkar W. Prenatal molecular diagnosis of beta-thalassemia and sickle cell anemia in the Syrian population. Hemoglobin. 2014;38:390\u20133.","journal-title":"Hemoglobin."},{"key":"1435_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/10245332.2018.1461291","volume":"23","author":"H Murad","year":"2018","unstructured":"Murad H, Moasses F, Dabboul A, Mukhalalaty Y, Bakoor AO, Al-Achkar W, Jarjour RA. Geographical distribution of beta-globin gene mutations in Syria. Hematology. 2018;23:697\u2013704.","journal-title":"Hematology"},{"key":"1435_CR16","first-page":"1","volume":"02","author":"MM Yassin","year":"2013","unstructured":"Yassin MM, Sirdah MM, Al Haddad RM, Lubbad AH, Al-Yazji MS. Genotype-phenotype characteristics of \u03b2 thalassemia children in the Gaza strip, Palestine. J Genet Disor Genet Rep. 2013;02:1\u20136.","journal-title":"J Genet Disor Genet Rep"},{"key":"1435_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/03630269.2012.747965","volume":"37","author":"N Liu","year":"2013","unstructured":"Liu N, Xie XM, Zhou JY, Li R, Liao C, Li DZ. Analysis of delta-globin gene mutations in the Chinese population. Hemoglobin. 2013;37:85\u201393.","journal-title":"Hemoglobin"},{"key":"1435_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2141.1982.tb02821.x","volume":"51","author":"P Fessas","year":"1982","unstructured":"Fessas P, Loukopoulos D, Loutradi-Anagnostou A, Komis G. 'Silent' beta-thalassaemia caused by a 'silent' beta-chain mutant: the pathogenesis of a syndrome of thalassaemia intermedia. Br J Haematol. 1982;51:577\u201383.","journal-title":"Br J Haematol"},{"key":"1435_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.V64.1.311.311","volume":"64","author":"SH Orkin","year":"1984","unstructured":"Orkin SH, Antonarakis SE, Loukopoulos D. Abnormal processing of beta Knossos RNA. Blood. 1984;64:311\u20133.","journal-title":"Blood"},{"key":"1435_CR20","first-page":"253","volume":"39","author":"A Gurgey","year":"1997","unstructured":"Gurgey A, Balkan H, Irken G, Gumruk F, Altay S, Kalaycioglu A, Oner C, Oner R. Compound heterozygosity for hemoglobin Knossos [alpha 2 beta 2 27 (B9) ala-Ser] and IVS I-1 mutation. Turk J Pediatr. 1997;39:253\u20137.","journal-title":"Turk J Pediatr"},{"key":"1435_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1749-6632.1990.tb24293.x","volume":"612","author":"C Altay","year":"1990","unstructured":"Altay C, Gurgey A. Beta-thalassemia intermedia in Turkey. Ann N Y Acad Sci. 1990;612:81\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"1435_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/gte.2006.0521","volume":"11","author":"I Keser","year":"2007","unstructured":"Keser I, Manguoglu E, Kayisli O, Yesilipek A, Luleci G. Combination of Hb Knossos [cod 27 (G-T)] and IVSII-745 (C-G) in a Turkish patient with beta-thalassemia major. Genet Test. 2007;11:228\u201330.","journal-title":"Genet Test"},{"key":"1435_CR23","doi-asserted-by":"crossref","unstructured":"Sun M, Lou J, Zhao Y, Liu Y. Molecular and Hematological Characterization of Two Novel delta-Globin Gene Mutations Found in Chinese Individuals. Hemoglobin. 2018;42:132-134.","DOI":"10.1080\/03630269.2018.1458628"},{"key":"1435_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1309\/AJCPPBQ8UB1WHXTS","volume":"142","author":"D Velasco-Rodriguez","year":"2014","unstructured":"Velasco-Rodriguez D, Alonso-Dominguez JM, Gonzalez-Fernandez FA, Villarrubia J, Ropero P, Martinez-Nieto J, de la Fuente F, Guillen R, Acedo N, Seri C. Cava F. Deltabeta-thalassemia trait: how can we discriminate it from beta-thalassemia trait and iron deficiency anemia? Am J Clin Pathol. 2014;142:567\u201373.","journal-title":"Am J Clin Pathol"},{"key":"1435_CR25","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1515\/cclm-2012-0102","volume":"50","author":"CA Sahli","year":"2012","unstructured":"Sahli CA, Bibi A, Ouali F, Siala H, Fredj SH, Othmani R, Ouenniche F, Cheour M, Fitouri Z, Becher SB, Messaoud T. \u03b40-thalassemia in cis of \u03b2 Knossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C \u2192 T) in thalassemia intermedia Tunisian patients. Clin Chem Lab Med. 2012;50:1743\u20138.","journal-title":"Clin Chem Lab Med"},{"key":"1435_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2141.1991.tb04460.x","volume":"78","author":"RJ Olds","year":"1991","unstructured":"Olds RJ, Sura T, Jackson B, Wonke B, Hoffbrand AV, Thein SL. A novel delta 0 mutation in cis with Hb Knossos: a study of different genetic interactions in three Egyptian families. Br J Haematol. 1991;78:430\u20136.","journal-title":"Br J Haematol"},{"key":"1435_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/03630260008997527","volume":"24","author":"R Oner","year":"2000","unstructured":"Oner R, Birben E, Acar C, Oner C, Kara A, Gumruk F, Gurgey A, Altay C. Molecular analysis of turkish beta-thalassemia heterozygotes with normal Hb A2 levels. Hemoglobin. 2000;24:195\u2013201.","journal-title":"Hemoglobin"},{"key":"1435_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12288-014-0343-y","volume":"30","author":"H Nasouhipur","year":"2014","unstructured":"Nasouhipur H, Banihashemi A, Youssefi Kamangar R, Akhavan-Niaki H. Hb Knossos: HBB:c.82G>T associated with HBB:c.315+1G>a Beta zero mutation causes thalassemia intermedia. Indian J Hematol Blood Transfus. 2014;30:243\u20135.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"1435_CR29","first-page":"139","volume":"8","author":"R Aditya","year":"2006","unstructured":"Aditya R, Verma IC, Saxena R, Kaul D, Khanna VK. Relation of Xmn-1 Polymorphism & Five Common Indian Mutations of Thalassaemia with phenotypic presentation in b-Thalassaemia. JK Sci. 2006;8:139\u201343.","journal-title":"JK Sci"},{"key":"1435_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bcmd.2015.02.001","volume":"54","author":"C Pereira","year":"2015","unstructured":"Pereira C, Relvas L, Bento C, Abade A, Ribeiro ML, Manco L. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin. Blood Cells Mol Dis. 2015;54:315\u201320.","journal-title":"Blood Cells Mol Dis"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1435-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1435-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1435-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T10:31:13Z","timestamp":1582021873000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1435-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1435-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"12 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that the parents of the proband signed written informed consent for publication of their own and children\u2019s genetic data, clinical details.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"61"}}